Fucoidan clinical trials
How each study uses fucoidan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the fucoidan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Fucoidan
- 6
Studies by the year they started
8 studies that test it; most in 2022 (5)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 5 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 6
Taipei Medical University WanFang Hospital (2) · Hi-Q Marine Biotech International, Ltd. (1) · Marinova Pty Ltd (1) · Peking University People's Hospital (1) · National University of Singapore (1) · Nanjing First Hospital, Nanjing Medical University (1) · Chang Gung Memorial Hospital (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test fucoidan.
- Dec 2026Fucoidan in the Treatment of Active Rheumatoid ArthritisNot applicable · Peking University People's Hospital
- Mar 2027Project SIRT6 ActivatorNot applicable · National University of Singapore
Studies
Open first, then newest update. How each study uses fucoidan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Fucoidan in the Treatment of Active Rheumatoid ArthritisRecruitingNot applicablePeking University People's HospitalNCT07045896Written as Fucoidan
- Project SIRT6 ActivatorRecruitingNot applicableNational University of SingaporeNCT07500649Written as Fucoidan
- Fucoidan Assisted Eradication of Helicobacter PyloriRecruitingPhase 1/2Nanjing First Hospital, Nanjing Medical UniversityNCT05461508Written as Amoxicillin combined with vonoprazan and fucoidan
- The Impact of Oligo-Fucoidan in Cancer Cachexia and SarcopeniaRecruitingNot applicableTaipei Medical University WanFang HospitalNCT05623852Written as fucoidan
- Oligo-Fucoidan Decrease Lung Radiation DamageRecruitingNot applicableTaipei Medical University WanFang HospitalNCT05616507Written as fucoidan
- A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and NeckCompletedPhase 2Hi-Q Marine Biotech International, Ltd.NCT04597476Written as Fucoidan
- Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic DermatitisStatus unknownNot applicableChang Gung Memorial HospitalNCT05437887Written as Fucoidan
- Inflammatory and Immune Response After High Intensity ExerciseCompletedNot applicableMarinova Pty LtdNCT05277727Written as Fucoidan 500mg
Given beside what is tested · 1 — fucoidan is usual care or a partner of the new treatment
Codes
What other systems call fucoidan · ClinicalTrials.gg INT002404
- MeSH (NLM) C007789fucoidanOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C007789 | fucoidan | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.